Mechanisms of vasorelaxant effect of dehydroevodiamine: A bioactive isoquinazolinocarboline alkaloid of plant origin

Journal of Cardiovascular Pharmacology

Volumn 27, Issue 6, 1996, Pages 845-853

  Chiou, Wen Fei ^a   Liao, Jyh Fei ^b   Shum, Andrew Yau Chik ^b   Chen, Chieh Fu ^a,b  

^a NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

1 Adrenoceptor; Ca2+ channel; Dehydroevodiamine (DeHE); Endothelium; K+ channel

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; DEHYDROEVODIAMINE; INDOMETACIN; METHYLENE BLUE; N(G) NITROARGININE; PHENYLEPHRINE; POTASSIUM CHANNEL; POTASSIUM CHLORIDE; POTASSIUM ION; PRAZOSIN; QUINAZOLINONE DERIVATIVE; TETRYLAMMONIUM;

ALPHA ADRENERGIC RECEPTOR BLOCKING; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY ENDOTHELIUM; ARTICLE; CHINESE HERB; CONTROLLED STUDY; DOSE RESPONSE; DRUG RECEPTOR BINDING; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; RAT; VASODILATATION;

ALKALOIDS; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; MALE; MESENTERIC ARTERIES; MINOXIDIL; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE SYNTHASE; NITROARGININE; RATS; RATS, SPRAGUE-DAWLEY; VASODILATION; VASODILATOR AGENTS;

EID: 0029942141     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199606000-00012     Document Type: Article

References (35)

1. Yang HY, Li SY, Chen CF. Hypotensive effects of dehydroevodiamine, a quinazolinocarboline alkaloid isolated from Evodia rutaecarpa. Asia Pac J Pharmacol 1989;3: 191-6.
2. Lin CI, Loh SH, Luk HN, Lue WM, Chen CF. Electropharmacological effects of dehydroevodiamine on mammalian hearts. J Chin Med 1990;1:84-93.
3. Loh SH, Lee AR, Huang WH, Lin CI. Ionic mechanisms responsible for the antiarrhythmic action of dehydroevodiamine in guinea-pig isolated cardiomyocytes. Br J Pharmacol 1992;106:517-23.
4. Yang MCM, Wu SL, Kao JS, Chen CF. The hypotensive and negative chronotropic effect of dehydroevodiamine. Eur J Pharmacol 1990;182:537-42.
5. Furchgott RF. The role of endothelium in the response of vascular smooth muscle to drugs. Annu Rev Pharmacol Toxicol 1984;24:175-97.
6. Vanhoutte PM. Endothelium and control of vascular function. Hypertension 1989;13:658-67.
7. De Mey JG, Claeys M, Vanhoutte PM. Endothelium dependent inhibitory effects of acetylcholine, adenosine triphosphate, thrombin, and arachidonic acid in the canine femoral artery. J Pharmacol Exp Ther 1982;222:166-73.
8. 2 and isoproterenol on the tissue cyclic AMP content in longitudinal muscle of rabbit intestine. Prostaglandins 1981;22: 159-65.
9. Chiou WF, Chou CJ, Liao JF, Shum AYC, Chen CF. The mechanism of the vasodilator effect of rutaecarpine, an alkaloid isolated from Evodia rutaecarpa. Eur J Pharmacol 1994;257:59-66.
10. + permeability. J Pharmadol Exp Ther 1988;245: 751-60.
11. Hamilton TC, Weir SW, Weston AH. Comparison of the effects of BRL-34915 and verapamil on electrical and mechanical activity in rat portal vein. Br J Pharmacol 1966;88: 103-11.
12. Watanabe AM. The role of potassium channels in vascular relaxation. J Cardiovasc Pharmacol 1988;12:S1-5.
13. Cook NS. The pharmacology of potassium channels and their therapeutic potential. Trends Pharmacol Sci 1988;9: 21-7.
14. Masuda Y, Arakawa C, Yokoyama T, Shigenobu K, Tanaka S. The antihypertensive property of NIP-121, a novel potassium channel opener in rats. J Cardiovasc Pharmacol 1991; 18:190-7.
15. Chiou WF, Chou CJ, Shum AYC, Chen CF. The vasorelaxant effect of evodiamine in rat isolated mesenteric arteries: mode of action. Eur J Pharmacol 1992;215:277-83.
16. G-nitroarginine (L-NOARG) inhibits endothelium dependent vasodilatation in the rabbit aorta and perfused rat mesentery. Br J Pharmacol 1989;98:905P.
17. Martin W, Villani GM, Furchgott RF. Hemoglobin and methylene blue selectively inhibit relaxation of rabbit aorta by agents which increase cyclic GMP levels [Abstract]. Fed Proc 1984;43:737.
18. + channel-dependent vasodilators. J Pharmacol Methods 1990;24:251-61.
19. 1-adrenoceptors of portal hypertensive rats. Br J Pharmacol 1994;111:439-44.
20. 50) of an enzymatic reaction. Biochem Pharmacol 1973;22:3099-108.
21. Lin LC, Chou CJ, Chen KT, Chen CF. Flavonoids from Evodia fructus. J Chin Med 1991;2:94-101.
22. Komor K, Suzuki H. Electrical responses of smooth muscle cells during cholinergic vasodilatation in the rabbit saphenous artery. Circ Res 1987;61:586-93.
23. Vanhoutte PM. The end of quest? Nature 1987;327:459-60.
24. Beny JL, Brunet PC. Neither nitric oxide nor nitroglycerin accounts for all the characteristics of endothelially mediated vasodilatation of pig coronary arteries. Blood Vessels 1988; 25:3-9.
25. Feletou M, Vanhoutte PM. Endothelium-dependent hyperpolarization of canine coronary smooth muscle. Br J Pharmacol 1988;93:515-24.
26. Chiou WF, Liao JF, Chen CF. Comparative study on the vasodilatory effects of three quinazoline alkaloids isolated from Evodia rutaecarpa. J Natl Prod 1996 (in press).
27. 2 serotonergic receptors. J Pharmacol Exp Ther 1981;218:217-30.
28. Vanhoutte PM, Cohen RA, Van Nueten JM. Serotonin and arterial vessels. J Cardiovasc Pharmacol 1984;2:S421-8.
29. Nagao T, Sadoshima S, Kamouchi M, Fujishima M. Cromakalim dilates rat cerebral arteries in vitro. Stroke 1991; 22:221-4.
30. +-contracted canine mesenteric artery. Br J Pharmacol 1990; 100:143-9.
31. + channels? Trends Pharmacol Sci 1993;14: 332-7.
32. Karaki H, Weiss GB. Calcium channel in smooth muscle. Gastroenterology 1984;87:960-9.
33. + channels in arterial and intestinal smooth muscle membranes. Pflugers Arch 1985;403:120-7.
34. Aschcroft FM. Adenosine triphosphate-sensitive potassium channels. Annu Rev Neurosci 1988;11:97-118.
35. Winquist RJ, Heaney LA, Wallace AA, et al. Glyburide blocks the relaxation vascular responses to BRL-34915 (cromakalim), minoxidil sulfate, and diazoxide in smooth muscle. J Pharmacol Exp Ther 1989;248:149-56.